Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo

Nanotechnology

Volumn 24, Issue 10, 2013, Pages

  Yin, Di ^a   Li, Yang ^a   Lin, Hang ^b   Guo, Baofeng ^a   Du, Yanwei ^a   Li, Xin ^a   Jia, Huijie ^a   Zhao, Xuejian ^a   Tang, Jun ^b   Zhang, Ling ^a  

^a Basic Medical College   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-TUMORS; ANTITUMOR EFFECT; BIOMEDICAL APPLICATIONS; BIOMEDICAL FIELDS; BLOOD CHEMISTRY; DELIVERY SYSTEMS; DOWN-REGULATION; FUNCTIONALIZED; GRAPHENE OXIDES; HISTOLOGICAL EXAMINATION; HUMAN CANCER; IN-VIVO; MALIGNANT MELANOMA; POLYETHYLENIMINES; SIDE EFFECT; SIGNAL TRANSDUCERS; SIRNA DELIVERY; SMALL INTERFERING RNA (SIRNA); TUMOR GROWTH; WIDE SPECTRUM;

CHEMICAL ACTIVATION; DERMATOLOGY; DISEASES; FUNCTIONAL POLYMERS; GRAPHENE; MAMMALS; MEDICAL APPLICATIONS; ONCOLOGY; POLYETHYLENE GLYCOLS; RNA; TUMORS;

DNA;

GRAPHITE; MACROGOL DERIVATIVE; NANOMATERIAL; OXIDE; POLYETHYLENEIMINE; SMALL INTERFERING RNA; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL PROLIFERATION; CHEMISTRY; EXPERIMENTAL MELANOMA; FLOW CYTOMETRY; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; MELANOMA; METABOLISM; METHODOLOGY; MOUSE; NANOTECHNOLOGY; NEOPLASM; PATHOLOGY; PLASMID; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GENETIC THERAPY; GRAPHITE; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; NANOSTRUCTURES; NANOTECHNOLOGY; NEOPLASM TRANSPLANTATION; NEOPLASMS; OXIDES; PLASMIDS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 84874240212     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/24/10/105102     Document Type: Article

References (42)

1. Wu M T, Wu R H, Hung C F, Cheng T L, Tsai W H and Chang W T 2005 Simple and efficient DNA vector-based RNAi systems in mammalian cells Biochem. Biophys. Res. Commun. 330 53-9 (Pubitemid 40394935)
2. Alshamsan A, Hamdy S, Samuel J, El-Kadi A O, Lavasanifar A and Uludag H 2010 The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine Biomaterials 31 1420-8
3. Tian B, Wang C, Zhang S, Feng L and Liu Z 2011 Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide ACS Nano 5 7000-9
4. Feng L, Zhang S and Liu Z 2011 Graphene based gene transfection Nanoscale 3 1252-7
5. Sun X, Liu Z, Welsher K, Robinson J T, Goodwin A, Zaric S and Dai H 2008 Nano-graphene oxide for cellular imaging and drug delivery Nano Res. 1 203-12
6. Yang K, Zhang S, Zhang G, Sun X, Lee S T and Liu Z 2010 Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy Nano Lett. 10 3318-23
7. Zhang L, Xia J, Zhao Q, Liu L and Zhang Z 2010 Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs Small 6 537-44
8. Lu C H, Yang H H, Zhu C L, Chen X and Chen G N 2009 A graphene platform for sensing biomolecules Angew. Chem. Int. Edn Engl. 48 4785-7
9. Zhang L, Lu Z, Zhao Q, Huang J, Shen H and Zhang Z 2011 Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide Small 7 460-4
10. Bromberg J F, Wrzeszczynska M H, Devgan G, Zhao Y, Pestell R G, Albanese C and Darnell J E Jr 1999 Stat3 as an oncogene Cell 98 295-303 (Pubitemid 29380565)
11. Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu D V, Kopecko D J, Zhao X and Xu D Q 2005 Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo Clin. Cancer Res. 11 6333-41 (Pubitemid 41262965)
12. Frank D A 2003 StAT signaling in cancer: insights into pathogenesis and treatment strategies Cancer Treat. Res. 115 267-91
13. Inghirami G, Chiarle R, Simmons W J, Piva R, Schlessinger K and Levy D E 2005 New and old functions of STAT3: a pivotal target for individualized treatment of cancer Cell Cycle 4 1131-3 (Pubitemid 41365374)
14. Yu H and Jove R 2004 The STATs of cancer - new molecular targets come of age Nature Rev. Cancer 4 97-105 (Pubitemid 38198738)
15. Zhang L et al 2007 Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs Cancer Res. 67 5859-64 (Pubitemid 46985020)
16. Liang Z W et al 2011 Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo Asian J. Androl. 13 481-6
17. Jia H et al 2012 Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma Cancer Immunol. Immunother. 61 1977-87
18. Yang K, Wan J, Zhang S, Zhang Y, Lee S T and Liu Z 2011 in vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice ACS Nano 5 516-22
19. Zhang L et al 2008 Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth Clin. Cancer Res. 14 559-68 (Pubitemid 351226126)
20. Tian Y et al 2012 Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC Cancer Gene Ther. 19 393-401
21. Fischer A, Hacein-Bey S, Le D F, de Saint B G, de Villartay J P and Cavazzana-Calvo M 2000 Gene therapy for immune deficiencies Bull. Acad. Natl. Med. 184 1417-28
22. Rekha M R and Sharma C P 2011 Hemocompatible pullulan-polyethyleneimine conjugates for liver cell gene delivery: in vitro evaluation of cellular uptake, intracellular trafficking and transfection efficiency Acta Biomater. 7 370-9
23. Lee H, Jeong J H and Park T G 2001 A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide J. Control. Release 76 183-92 (Pubitemid 32786895)
24. Putnam D, Gentry C A, Pack D W and Langer R 2001 Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini Proc. Natl Acad. Sci. USA 98 1200-5 (Pubitemid 32121210)
25. Chang Y, Yang S T, Liu J H, Dong E, Wang Y, Cao A, Liu Y and Wang H 2011 In vitro toxicity evaluation of graphene oxide on A549 cells Toxicol. Lett. 200 201-10
26. Lewinski N, Colvin V and Drezek R 2008 Cytotoxicity of nanoparticles Small 4 26-49 (Pubitemid 351205731)
27. Mates J M, Segura J A, Alonso F J and Marquez J 2008 Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis Arch. Toxicol. 82 273-99
28. Genestra M 2007 Oxyl radicals, redox-sensitive signalling cascades and antioxidants Cell Signal 19 1807-19 (Pubitemid 47090178)
29. Neu M, Fischer D and Kissel T 2005 Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives J. Gene Med. 7 992-1009 (Pubitemid 41195062)
30. Zhu J, Tang A, Law L P, Feng M, Ho K M, Lee D K, Harris F W and Li P 2005 Amphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriers Bioconjug. Chem. 16 139-46 (Pubitemid 40129687)
31. Lee S O, Lou W, Qureshi K M, Mehraein-Ghomi F, Trump D L and Gao A C 2004 RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells Prostate 60 303-9 (Pubitemid 39050649)
32. Mora L B et al 2002 Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells Cancer Res. 62 6659-66 (Pubitemid 35364135)
33. Konnikova L, Kotecki M, Kruger M M and Cochran B H 2003 Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells BMC Cancer 3 23 (Pubitemid 38851326)
34. Garcia R et al 2001 Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells Oncogene 20 2499-513 (Pubitemid 32531347)
35. Leong P L et al 2003 Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth Proc. Natl Acad. Sci. USA 100 4138-43 (Pubitemid 36418170)
36. Germain D and Frank D A 2007 Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy Clin. Cancer Res. 13 5665-9 (Pubitemid 47583890)
37. Li Y, Liu Y, Fu Y, Wei T, Le G L, Gao G, Liu R S, Chang Y Z and Chen C 2012 The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways Biomaterials 33 402-11
38. Ni Z, Lou W, Leman E S and Gao A C 2000 Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells Cancer Res. 60 1225-8 (Pubitemid 30151988)
39. Alas S and Bonavida B 2001 Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs Cancer Res. 61 5137-44 (Pubitemid 32681546)
40. Robinson J T, Tabakman S M, Liang Y, Wang H, Casalongue H S, Vinh D and Dai H 2011 Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy J. Am. Chem. Soc. 133 6825-31
41. Qin Y, Kim Y, Zhang L, Lee S M, Yang R B, Pan A, Mathwig K, Alexe M, Gosele U and Knez M 2010 Preparation and elastic properties of helical nanotubes obtained by atomic layer deposition with carbon nanocoils as templates Small 6 910-4
42. Chen Z and Han Z C 2008 STAT3: a critical transcription activator in angiogenesis Med. Res. Rev. 28 185-200 (Pubitemid 351281185)